Malaria Vaccine Candidate 'Impressive' in Phase III Test

(MedPage Today) -- SEATTLE--A much-anticipated malaria vaccine candidate demonstrated an overall efficacy of 75% in young children, and with no serious safety concerns, results from a phase III trial spanning four African nations showed.
In...